Thermo Fisher Scientific Inc (NYSE:TMO)
| 493.19 Delayed Data As of Nov 29 |  +7.27 / +1.50%Today’s Change | 415.60 Today|||52-Week Range 609.85 | -10.44% Year-to-Date |
Latest TMO News | Press Releases
| The Investment Case for Thermo Fisher Scientific Inc (TMO): How Financial Growth and Innovation ... Nov 27 / GuruFocus News - Paid Partner Content | Why Is Thermo Fisher (TMO) Up 10.8% Since Last Earnings Report? Nov 24 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 485.92 |
| Today’s open | 490.44 |
| Day’s range | 490.26 - 495.77 |
| Volume | 1,195,835 |
| Average volume (3 months) | 1,670,416 |
| Market cap | $189.6B |
Data as of 4:00pm ET, 11/29/2023
Growth & Valuation
| Earnings growth (last year) | -9.57% |
| Earnings growth (this year) | +1.46% |
| Earnings growth (next 5 years) | -1.85% |
| Revenue growth (last year) | +14.55% |
| P/E ratio | 32.3 |
| Price/Sales | 4.83 |
| Price/Book | 4.36 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| DHRDanaher Corp | +3.75 | +1.71% |
| AAgilent Technologies... | +2.88 | +2.31% |
| MTDMettler-Toledo Inter... | +10.54 | +0.97% |
| WATWaters Corp | +3.70 | +1.34% |
Data as of 3:59pm ET, 11/29/2023
Financials
| Next reporting date | January 31, 2024 |
| EPS forecast (this quarter) | $7.02 |
| Annual revenue (last year) | $44.9B |
| Annual profit (last year) | $7.0B |
| Net profit margin | 15.47% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Waltham, Massachusetts |
Forecasts
